Cabaletta Bio, a Philadelphia-based biotechnology company, has announced promising results from its recent clinical trial involving CAR-T therapy for a rare autoimmune disorder. The findings indicate...
The federal 340B program, designed to assist safety-net clinics and hospitals in providing care for low-income and uninsured patients, is facing significant scrutiny for its shortcomings....
Patients often lack a comprehensive understanding of the long-term complications associated with shingles, a viral infection known for causing painful rashes. Educational efforts by healthcare providers...
The long-term complications associated with shingles, a viral infection caused by the varicella-zoster virus, are often underestimated by patients. Effective educational strategies are essential for conveying...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance that mandates the inclusion of overall survival (OS) data in all randomized clinical trials...
